{"id":509,"date":"2026-01-07T03:37:48","date_gmt":"2026-01-06T20:37:48","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/"},"modified":"2026-01-07T03:37:48","modified_gmt":"2026-01-06T20:37:48","slug":"amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/","title":{"rendered":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris"},"content":{"rendered":"<div id=\"block-content\"> <astro-island uid=\"ZHipbw\" prefix=\"r63\" component-url=\"\/_astro\/figure.CMLsvaFi.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_key&quot;:(0,&quot;fa816e8b596d&quot;),&quot;_type&quot;:(0,&quot;figure&quot;),&quot;alignment&quot;:(0,&quot;left&quot;),&quot;alt&quot;:(0,&quot;Leukemia Awareness: Photomicrograph of bone marrow aspirate showing myeloblasts of acute myeloid leukemia (AML), a cancer of white blood cells. | Image Credit: \u00a9David A Litman -stock.adobe.com&quot;),&quot;asset&quot;:(0,{&quot;_ref&quot;:(0,&quot;image-ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720-jpg&quot;),&quot;_type&quot;:(0,&quot;reference&quot;)}),&quot;disableLightBox&quot;:(0,true),&quot;imageFit&quot;:(0,&quot;crop&quot;),&quot;imgcaption&quot;:(1,((0,{&quot;_key&quot;:(0,&quot;1883c208d11a&quot;),&quot;_type&quot;:(0,&quot;block&quot;),&quot;children&quot;:(1,((0,{&quot;_key&quot;:(0,&quot;f0884e870973&quot;),&quot;_type&quot;:(0,&quot;span&quot;),&quot;marks&quot;:(1,()),&quot;text&quot;:(0,&quot;Leukemia Awareness: Photomicrograph of bone marrow aspirate showing myeloblasts of acute myeloid leukemia (AML), a cancer of white blood cells. | Image Credit: \u00a9David A Litman -stock.adobe.com&quot;)}))),&quot;markDefs&quot;:(1,()),&quot;style&quot;:(0,&quot;normal&quot;)}))),&quot;medias&quot;:(0,null),&quot;uploadAudio&quot;:(0,null),&quot;upload_doc&quot;:(0,null),&quot;widthP&quot;:(0,30)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;FigurePlugin&quot;,&quot;value&quot;:true}\"\/><\/p>\n<p class=\"\">Amgen mengumumkan pada 6 Januari 2026 bahwa mereka telah mengakuisisi Dark Blue Therapeutics, sebuah perusahaan bioteknologi yang berlokasi di Inggris (1). Transaksi tersebut, yang bernilai hingga $840 juta, menambahkan molekul kecil yang sedang diselidiki ke dalam portofolio Amgen yang menargetkan dan mendegradasi dua protein (MLLT1\/3) yang mendorong jenis leukemia myeloid akut (AML) tertentu. Menurut perusahaan tersebut, aktivitas anti-kanker dan diferensiasi mekanistik telah ditunjukkan oleh data praklinis dalam model leukemia, yang menunjukkan penggunaan agen tunggal dan kombinasi dapat digunakan untuk mengatasi resistensi pengobatan dan meningkatkan ketahanan remisi (1).<\/p>\n<p class=\"\">\u201cLeukemia myeloid akut tetap menjadi salah satu kanker yang paling sulit diobati, dan kami melihat kebutuhan mendesak akan mekanisme baru yang mampu mengubah arah penyakit ini,\u201d kata Jay Bradner, MD, wakil presiden eksekutif Penelitian dan Pengembangan di Amgen, dalam siaran persnya (1). \u201cAkuisisi ini melengkapi dan memperluas penelitian kami dalam degradasi protein tertarget dan terapi leukemia, sehingga memajukan strategi kami untuk berinvestasi sejak dini dalam meningkatkan obat-obatan untuk target terapi baru. Kedekatan program ini dengan keahlian kami dalam biologi kanker akan mendorong obat-obatan yang menargetkan MLLT1\/3 ke dalam penyelidikan klinis bagi pasien yang menghadapi tantangan diagnosis AML.\u201d<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Tindakan bisnis apa yang dilakukan Amgen baru-baru ini?<\/strong><\/h2>\n<p class=\"\">Pada 19 Desember 2025, Amgen mengumumkan komitmennya untuk mengurangi biaya obat-obatan sambil terus berinovasi dalam menanggapi permintaan harga Most Favored Nation dari Pemerintahan Trump (2). Perusahaan menyatakan sedang memperluas program langsung ke pasien, AmgenNow, untuk memasukkan Aimovig (erenumab-aooe) dan Amjevita (adalimumab-atto) dengan harga diskon bulanan. Amgen meluncurkan program ini pada bulan Oktober 2025 dengan Repatha\u00ae (evolocumab), yang tersedia dengan harga 60% di bawah harga jual AS saat ini (2).<\/p>\n<p class=\"\">Menurut perusahaan tersebut, investasinya di bidang manufaktur AS, hingga $2,5 miliar pada tahun 2025, memungkinkannya memperoleh keringanan tarif khusus industri selama tiga tahun. Perusahaan sedang berinvestasi <astro-island uid=\"VogmQ\" prefix=\"r56\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;b8d2490224a5&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;$900\u00a0million\u00a0in\u00a0Ohio&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;025e5bbc3a06&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4584736-1&amp;h=873188505&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4519515-1%26h%3D3644437420%26u%3Dhttps%253A%252F%252Fwwwext.amgen.com%252Fnewsroom%252Fpress-releases%252F2025%252F04%252Famgen-announces-900-million-manufacturing-expansion-creation-of-350-new-jobs-in-ohio%26a%3D%2524900%2Bmillion%2Bin%2BOhio&amp;a=%24900+million%C2%A0in%C2%A0Ohio&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;025e5bbc3a06&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">$900 juta di Ohio<!--astro:end--><\/astro-island>  Dan <astro-island uid=\"Zv8KWV\" prefix=\"r57\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;a342599be59d&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;$1\u00a0billion\u00a0in\u00a0North Carolina&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;7c1105bdec62&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4584736-1&amp;h=2781156778&amp;u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4519515-1%26h%3D3725024736%26u%3Dhttps%253A%252F%252Fwwwext.amgen.com%252Fnewsroom%252Fpress-releases%252F2024%252F12%252Famgen-announces-%25241-billion-manufacturing-expansion-in-north-carolina%26a%3D%25241%2Bbillion%2Bin%2BNorth%2BCarolina&amp;a=%241+billion%C2%A0in%C2%A0North+Carolina&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;7c1105bdec62&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">$1 miliar di Carolina Utara<!--astro:end--><\/astro-island>    (2).<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Kemajuan apa lagi yang telah dicapai dalam pengobatan AML?<\/strong><\/h2>\n<p class=\"\">Pada bulan September 2025, hasil praklinis <astro-island uid=\"Z2vfdgP\" prefix=\"r58\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;9d8f7fd5a2c7&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;published in the journal\u00a0&quot;)}),(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;7a65338c88a4&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Leukemia&quot;)}))),&quot;markDef&quot;:(0),&quot;markType&quot;:(0,&quot;em&quot;),&quot;markKey&quot;:(0,&quot;em&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;0e2537fb8244&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.nature.com\/articles\/s41375-025-02705-4&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;0e2537fb8244&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">dipublikasikan di jurnal <em>Leukemia<\/em><!--astro:end--><\/astro-island>  menunjukkan kemanjuran terapi sel T reseptor antigen chimeric (CAR-T) yang dikembangkan oleh <astro-island uid=\"7Hv44\" prefix=\"r59\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;4d9cafbc743f&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Gyala Therapeutics&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;b74021276581&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.gyalatx.com\/&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;b74021276581&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Terapi Gyala<!--astro:end--><\/astro-island>GYA-01, melawan AML dan leukemia limfoblastik akut sel T (T-ALL) (3). Menurut Gyala Therapeutics, penelitian yang diterbitkan ini adalah yang pertama yang menyajikan data praklinis mengenai sel CAR-T yang menargetkan protein CD84, menyoroti protein tersebut sebagai target hematologi luas yang dapat memperluas peluang terapi CAR-T di luar keganasan sel B.<\/p>\n<p class=\"\">Menurut Gyala, banyak pasien AML mencapai remisi melalui kemoterapi pada awalnya; namun, hampir separuh pasien kambuh setelah pengobatan lini pertama (2). Dengan T-ALL, lebih dari 90% pasien anak-anak dapat bertahan hidup dengan kemoterapi, namun kelangsungan hidup jangka panjang pada orang dewasa jauh lebih rendah, yaitu sekitar 40% (3).<\/p>\n<p class=\"\">\u201cBukti praklinis yang diperoleh menegaskan bahwa GYA-01 adalah terapi CAR-T yang sangat menjanjikan, mendukung CD84 sebagai target pan-hematologi, dan menetapkan landasan yang kuat untuk melanjutkan uji klinis pada pasien dengan AML dan T-ALL,\u201d Nela Klein-Gonzalez, MD, PhD, direktur medis Gyala Therapeutics dan penulis buku <em>Leukemia<\/em> artikel, kata dalam siaran pers (3). \u201cDalam indikasi ini, tantangan utama terapi CAR-T adalah kurangnya target tumor yang spesifik.\u201d<\/p>\n<h2 class=\"pb-4 pt-2 text-2xl\"><strong>Referensi<\/strong><\/h2>\n<ol class=\"my-2\">\n<li class=\"ml-8 list-decimal\">Amgen. Amgen Mengakuisisi Terapi Biru Tua, Memperkuat Saluran Onkologi. Siaran Pers. 6 Januari 2026. <astro-island uid=\"Z1GKWaK\" prefix=\"r60\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;6052300116df&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;https:\/\/www.amgen.com\/newsroom\/press-releases\/2026\/01\/amgen-acquires-dark-blue-therapeutics-bolstering-oncology-pipeline&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;99b362a9a557&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.amgen.com\/newsroom\/press-releases\/2026\/01\/amgen-acquires-dark-blue-therapeutics-bolstering-oncology-pipeline&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;99b362a9a557&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">https:\/\/www.amgen.com\/newsroom\/press-releases\/2026\/01\/amgen-acquires-dark-blue-therapeutics-bolstering-oncology-pipeline<!--astro:end--><\/astro-island><\/li>\n<li class=\"ml-8 list-decimal\">Amgen. Amgen Mengambil Tindakan dengan Pemerintah AS untuk Menurunkan Biaya Obat bagi Pasien Amerika. Siaran Pers. 19 Desember 2025. <astro-island uid=\"Hxqhc\" prefix=\"r61\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;cd6de6a93922&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;https:\/\/www.amgen.com\/newsroom\/press-releases\/2025\/12\/amgen-takes-action-with-the-u-s--government-to-lower-the-cost-of-medicines-for-american-patients&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;0ea820e2e80b&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;blank&quot;:(0,true),&quot;href&quot;:(0,&quot;https:\/\/www.amgen.com\/newsroom\/press-releases\/2025\/12\/amgen-takes-action-with-the-u-s--government-to-lower-the-cost-of-medicines-for-american-patients&quot;),&quot;nofollow&quot;:(0,true)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;0ea820e2e80b&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">https:\/\/www.amgen.com\/newsroom\/press-releases\/2025\/12\/amgen-takes-action-with-the-us&#8211;pemerintah-to-lower-the-cost-of-medicines-for-american-patients<!--astro:end--><\/astro-island><\/li>\n<li class=\"ml-8 list-decimal\">Terapi Gyala. <astro-island uid=\"23MY0J\" prefix=\"r62\" component-url=\"\/_astro\/external-link.WtEnJL32.js\" component-export=\"default\" renderer-url=\"\/_astro\/client.4AZqD4Tw.js\" props=\"{&quot;value&quot;:(0,{&quot;_type&quot;:(0,&quot;@span&quot;),&quot;_key&quot;:(0,&quot;e06fbfafce1b&quot;),&quot;children&quot;:(1,((0,{&quot;_type&quot;:(0,&quot;@text&quot;),&quot;text&quot;:(0,&quot;Gyala Therapeutics Unveils First-in-Class CAR-T Therapy Targeting CD84 Showing Strong Preclinical Efficacy in Hard-to-Treat Leukemias.&quot;)}))),&quot;markDef&quot;:(0,{&quot;_key&quot;:(0,&quot;0e7f31be90f1&quot;),&quot;_type&quot;:(0,&quot;link&quot;),&quot;href&quot;:(0,&quot;https:\/\/www.gyalatx.com\/post\/gyala-therapeutics-unveils-first-in-class-car-t-therapy-targeting-cd84-showing-strong-preclinical-ef&quot;)}),&quot;markType&quot;:(0,&quot;link&quot;),&quot;markKey&quot;:(0,&quot;0e7f31be90f1&quot;)})}\" ssr=\"\" client=\"load\" opts=\"{&quot;name&quot;:&quot;ExternalLinkPlugin&quot;,&quot;value&quot;:true}\" await-children=\"\">Gyala Therapeutics Meluncurkan Terapi CAR-T Kelas Satu yang Menargetkan CD84 yang Menunjukkan Kemanjuran Praklinis yang Kuat pada Leukemia yang Sulit Diobati.<!--astro:end--><\/astro-island>  Siaran Pers. 15 September 2025.<\/li>\n<\/ol><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Amgen mengumumkan pada 6 Januari 2026 bahwa mereka telah mengakuisisi Dark Blue Therapeutics, sebuah perusahaan bioteknologi yang berlokasi di Inggris (1). Transaksi tersebut, yang bernilai hingga $840 juta, menambahkan molekul kecil yang sedang diselidiki ke dalam portofolio Amgen yang menargetkan dan mendegradasi dua protein (MLLT1\/3) yang mendorong jenis leukemia myeloid akut (AML) tertentu. Menurut perusahaan [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":510,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-509","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"Amgen mengumumkan pada 6 Januari 2026 bahwa mereka telah mengakuisisi Dark Blue Therapeutics, sebuah perusahaan bioteknologi yang berlokasi di Inggris (1). Transaksi tersebut, yang bernilai hingga $840 juta, menambahkan molekul kecil yang sedang diselidiki ke dalam portofolio Amgen yang menargetkan dan mendegradasi dua protein (MLLT1\/3) yang mendorong jenis leukemia myeloid akut (AML) tertentu. Menurut perusahaan [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-06T20:37:48+00:00\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris\",\"datePublished\":\"2026-01-06T20:37:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\"},\"wordCount\":546,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\",\"name\":\"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg\",\"datePublished\":\"2026-01-06T20:37:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/","og_locale":"id_ID","og_type":"article","og_title":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT","og_description":"Amgen mengumumkan pada 6 Januari 2026 bahwa mereka telah mengakuisisi Dark Blue Therapeutics, sebuah perusahaan bioteknologi yang berlokasi di Inggris (1). Transaksi tersebut, yang bernilai hingga $840 juta, menambahkan molekul kecil yang sedang diselidiki ke dalam portofolio Amgen yang menargetkan dan mendegradasi dua protein (MLLT1\/3) yang mendorong jenis leukemia myeloid akut (AML) tertentu. Menurut perusahaan [&hellip;]","og_url":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2026-01-06T20:37:48+00:00","author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"3 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris","datePublished":"2026-01-06T20:37:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/"},"wordCount":546,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg","articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/","url":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/","name":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg","datePublished":"2026-01-06T20:37:48+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#primaryimage","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2026\/01\/ed0a3a8b7bdfcc531bed77c539fa498930789792-1280x720.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2026\/01\/07\/amgen-mengakuisisi-biotech-dark-blue-therapeutics-inggris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"Amgen Mengakuisisi Biotech Dark Blue Therapeutics Inggris"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=509"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/509\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media\/510"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}